Diabetes (db/db) mutation-induced female reproductive tract hypercytolipidemia: Estrogenic restoration of utero-ovarian indices

Reproductive Toxicology

Volumn 18, Issue 5, 2004, Pages 641-651

  Garris, David R ^a   Garris, Bryan L ^a  

^a UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

Author keywords

+ ?; control (heterozygous) genotype of C57BL KsJ mice; db db; diabetes genotype mutation; Diabetes induced reproductive tract atrophy; diabetes obesity syndrome; DOS; E2 HRx; estradiol hormone therapy; Hypercytolipidemia; O HRx; oil vehicle (sham) therapy

Indexed keywords

ESTRADIOL; GLUCOSE; LEPTIN RECEPTOR; LIPID; OIL; TRIACYLGLYCEROL LIPASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATROPHY; BODY WEIGHT; CONTROLLED STUDY; CYTOARCHITECTURE; CYTOCHEMISTRY; DIABETES MELLITUS; DIABETIC OBESITY; ENVIRONMENT; ENZYME ACTIVITY; ESTROGEN THERAPY; FEMALE; FEMALE GENITAL SYSTEM; FEMALE STERILITY; GENE EXPRESSION; GENE MUTATION; GLUCOSE BLOOD LEVEL; GLUCOSE TRANSPORT; GLUCOSE UTILIZATION; HOMEOSTASIS; HYPERGLYCEMIA; HYPERINSULINEMIA; HYPERLIPIDEMIA; INVOLUTION; LOW DRUG DOSE; MOUSE; NONHUMAN; ORGAN WEIGHT; OVARY; PHENOTYPE; SEXUAL INTERCOURSE; TARGET CELL; TRANSCRIPTION REGULATION; UTERUS; UTERUS WEIGHT;

ANIMALS; ATROPHY; BODY WEIGHT; DIABETES MELLITUS; ESTRADIOL; FEMALE; GENOTYPE; HISTOCYTOCHEMISTRY; HYPERGLYCEMIA; HYPERINSULINISM; HYPERLIPIDEMIAS; INSULIN; MICE; MICE, INBRED C57BL; MUTATION; OBESITY; OVARY; RADIOIMMUNOASSAY; UTERUS;

EID: 3042528683     PISSN: 08906238     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.reprotox.2004.04.007     Document Type: Article

References (33)

1. Johnson L.M., Sidman R.L. A reproductive profile in the diabetes (db) mutant mouse. Biol. Reprod. 20:1979;552-559
2. Garris D.R., Garris B.L. Diabetes (db/db) mutation-induced ovarian involution: progressive hypercytolipidemia. Exp. Biol. Med. 228:2003;1040-1050
3. Garris D.R., Garris B.L. Diabetes-induced, progressive endometrial involution: characterization of periluminal epithelial lipoatrophy. Diabetes. 52:2003;51-58
4. Garris D.R., Garris B.L. Lipoatrophic diabetes-associated utero-ovarian dysfunction: influence of cellular lipid deposition on norepinephrine indices. Horm. Res. 58:2002;120-127
5. Garris D.R., Garris B.L. Cytolipotoxicity-induced involution of the female reproductive tract following expression of the obese (ob/ob) and diabetes (db/db) genotype mutations: progressive, hyperlipidemic transformation into adipocytic tissues. Reprod. Toxicol. 18:2004;81-91
6. Leibel R.L., Chung W.K., Chua S.C. Jr. The molecular basis of rodent single gene obesities. J. Biol. Chem. 272:1997;31937-31940
7. Garris B.L., Garris D.R. Ultrastructural analysis of progressive endometrial hypercytolipidemia induced by obese (ob/ob) and diabetes (db/db) genotype mutations: basis of female reproductive tract involution. Tissue Cell. 36:2004;19-28
8. Abbott D.H., Damesic D.A., Franks S. Jr. Development of polycystic ovary syndrome-a hypothesis. J. Endocrinol. 174:2002;1-5
9. Anderson B. Estrogen replacement therapy decreases hyperandrogenicity and improves glucose homeostasis and plasma lipids in postmenopausal women with non-insulin dependent diabetes mellitus. J. Clin. Endocrinol. Metabol. 82:1997;634-638
10. Chieri R.A., Pivetta O.H., Foglia V.G. Altered ovulation pattern in experimental diabetes. Fertil. Steril. 20:1969;661-668
11. Ewart-Toland A., Mounzih K., Qiu J., Chehab F. Effect of genetic background on the reproduction of leptin-deficient mice. Endocrinology. 140:1999;732-738
12. Coleman D.L., Leiter E.H., Schwizer R.W. Therapeutic effects of dehydroepiandrosterone (DHEA) in diabetic mice. Diabetes. 31:1982;830-833
13. Garris D.R. Effects of estradiol and progesterone on diabetes-associated utero-ovarian atrophy in C57BL/KsJ (db/db) mutant mice. Anat. Rec. 225:1989;310-317
14. Garris D.R. Estrogenic stimulation of hypothalamic-limbic system metabolism in ageing diabetic C57BL/KsJ mice. Neuroendocrinology. 69:1999;424-429
15. Unger R.H., Zhou Y.T. Lipotoxicity of B-cells in obesity and in other causes of fatty acid spillover. Diabetes. 50(Suppl. 1):2001;118-121
16. Garris D.R., Coleman D.L., Morgan C.R. Age- and diabetes-related changes in tissue glucose uptake and estradiol accumulation in the C57BL/KsJ mouse. Diabetes. 34:1985;47-52
17. Barlett P.B., Garris D.R. Peripheral tissue insulin uptake rates in female, obese-diabetic C57BL/KsJ (db/db) mice. Med. Sci. Res. 15:1987;1501-1502
18. Garris D.R. Effects of diabetes (db/db) mutation on brain and peripheral tissue insulin receptor binding in C57BL/KsJ mice: modulating actions of estradiol and progesterone. Med. Sci. Res. 16:1988;347-349
19. Garris B.L., Garris D.R. Digital chemospectrophotographic identification of intracellular hyperlipidemia is diabetic endometrial epithelial cells: structural and metabolic basis of organoatrophy. Pathobiology. 71:2004;77-83
20. Garris D.R. Depressed progesterone accumulation by the brain and peripheral tissues of diabetic C57BL/KsJ mice: normalization by estrogen therapy. Horm. Res. 25:1987;37-48
21. Morley J.E. Sex hormones and diabetes. Diabetes Rev. 6:1998;6-15
22. Coleman D.L. Antiobesity effects of eticholanolones in diabetes (db), viable yellow (Avy), and normal mice. Endocrinology. 117:1985;2279-2283
23. Leahy J.L. Impaired B-cell function with chronic hyperglycemia: overworked B-cell hypothesis. Diabetes Rev. 4:1996;298-319
24. Patti M.E., Kahn C.R. Transgenic animal models: insights into the pathophysiology of NIDDM. Diabetes Rev. 5:1997;149-164
25. Koyama K., Chen G., Lee Y., Unger R.H. Tissue triglycerides, insulin resistance and insulin production: implications for hyperinsulinemia of obesity. Am. J. Physiol. 273:1997;E708-E713
26. Segall L., Lameloise N., Assimacopulos-Jeannet F., Roche E., Corkey P., Thumelin S., et al. Lipid rather than glucose metabolism is implicated in altered insulin secretion caused by oleate in INS-1 cells. Am. J. Physiol. 277:1999;E521-E528
27. Garris D.R. The effects of estradiol and progesterone on reproductive tract atrophy and tissue adrenergic indices in diabetic C57BL/KsJ mice. Proc. Soc. Exp. Biol. Med. 193:1990;39-45
28. Coleman D.L., Leiter E.H., Appleweig N. Therapeutic effects of dehydroepiandrosterone (DHEA) metabolites in diabetes mutant mice (C57BL/KsJ-db/db). Endocrinology. 115:1984;239-243
29. Watson C.S., Gametchu B. Proteins of multiple classes may participate in nongenomic steroid actions. Exp. Biol. Med. 228:2003;1272-1281
30. Kim J.K., Fillmore J.J., Chen Y., Yu C., Moore I.K., Pypaert M., et al. Tissue-specific overexpression of lipoprotein lipase causes tissue-specific insulin resistance. Proc. Natl. Acad. Sci. 98:2001;7522-7527
31. Briaud I., Harmon J.S., Kelpe C.L., Segu V.B.G., Poitout V. Lipotoxicity of the pancreatic B-cell is associated with glucose-dependent esterification of fatty acids into neutral lipids. Diabetes. 50:2001;315-321
32. Unger R.H. Lipid overload and overflow: metabolic trauma and the metabolic syndrome. Trends Endocrinol. Metabol. 14:2003;398-403
33. Gonzalez C., Alonso A., Grueso N.A., Diaz F., Esteban M.M., Fernandez S., et al. Effect of treatment with different doses of 17-B-estradiol on insulin receptor substrate-1. J. Pancreas. 2:2001;140-149